Mongolia has the world’s highest rate of liver cancer mortality; nearly eight times the global average. The prevalence of chronic viral hepatitis B, C, and D is at endemic level, and constitutes the main reason cause of Mongolia’s world-leading liver cancer mortality rate. To tackle this deadly crisis, the Onom Foundation, Patient and Civil Society Council, Mongolian Gastroenterology Association, and Mongolian Society of Hepatology launched the Hepatitis Prevention, Control, and Elimination (HPCE).
The European Parliament adopted a resolution on the EU’s response to HIV/AIDS, Tuberculosis and Hepatitis C
The European Parliament adopted a resolution on the EU’s response to HIV/AIDS, Tuberculosis and Hepatitis C, prepared by its Committee on the Environment, Public Health and Food Safety.
NASH-CORE findings to be unveiled in conjunction with the First EASL NAFLD Summit
The global prevalence of non-alcoholic fatty liver disease (NAFLD) is 25%. It is considered to be endemic in Europe and a major potential threat to public health. Yet it appears to receive very limited attention. EASL International Liver Foundation aims to place the spotlight on NALFD and take the first important step needed to generate a call to action by developing an understanding of what government and key stakeholders such as medical associations and patient groups are currently doing.
Elimination of Viral Hepatitis in Chronic Kidney Disease patients: a call to action
We are honoured to announce that we have joined forces with the European Renal Association- European Dialysis and Transplant Association (ERA-EDTA) to bring together expert Hepatologists and Nephrologists to eliminate viral hepatitis among patients with chronic kidney disease (CKD).
To solve the huge challenges we face as a society we need to help everyone in the field maximize the full potential of their talents and intellect. Then they can mobilize those skills to help us solve our most difficult problems. That’s why education is central to us achieving our goals.